List of Tables
Table 1. Global Peripheral Intervention Drug-Eluting Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Peripheral Intervention Drug-Eluting Devices Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Peripheral Intervention Drug-Eluting Devices Market Competitive Situation by Manufacturers in 2024
Table 4. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Peripheral Intervention Drug-Eluting Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Peripheral Intervention Drug-Eluting Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Product Type & Application
Table 12. Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peripheral Intervention Drug-Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peripheral Intervention Drug-Eluting Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2020-2025) & (K Units)
Table 18. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2020-2025)
Table 19. Global Peripheral Intervention Drug-Eluting Devices Sales by Region (2026-2031) & (K Units)
Table 20. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2026-2031)
Table 21. Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2020-2025)
Table 23. Global Peripheral Intervention Drug-Eluting Devices Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2026-2031)
Table 25. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 27. North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2026-2031) & (K Units)
Table 28. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 32. Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2026-2031) & (K Units)
Table 33. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2020-2025)
Table 51. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2026-2031)
Table 52. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2020-2025)
Table 53. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2026-2031)
Table 54. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2020-2025)
Table 57. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2026-2031)
Table 58. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Type (2020-2025)
Table 59. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Type (2026-2031)
Table 60. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2020-2025)
Table 61. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2026-2031)
Table 62. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2020-2025)
Table 63. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2026-2031)
Table 64. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2020-2025)
Table 67. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2026-2031)
Table 68. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Application (2020-2025)
Table 69. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Application (2026-2031)
Table 70. Medtronic plc Company Information
Table 71. Medtronic plc Description and Business Overview
Table 72. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product
Table 74. Medtronic plc Recent Developments/Updates
Table 75. Boston Scientific Corporation Company Information
Table 76. Boston Scientific Corporation Description and Business Overview
Table 77. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product
Table 79. Boston Scientific Corporation Recent Developments/Updates
Table 80. Abbott Laboratories Company Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product
Table 84. Abbott Laboratories Recent Developments/Updates
Table 85. Cardinal Health Company Information
Table 86. Cardinal Health Description and Business Overview
Table 87. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product
Table 89. Cardinal Health Recent Developments/Updates
Table 90. B. Braun Melsungen AG Company Information
Table 91. B. Braun Melsungen AG Description and Business Overview
Table 92. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product
Table 94. B. Braun Melsungen AG Recent Developments/Updates
Table 95. Biosensors International Group Ltd. Company Information
Table 96. Biosensors International Group Ltd. Description and Business Overview
Table 97. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product
Table 99. Biosensors International Group Ltd. Recent Developments/Updates
Table 100. C.R. Bard, Inc. Company Information
Table 101. C.R. Bard, Inc. Description and Business Overview
Table 102. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product
Table 104. C.R. Bard, Inc. Recent Developments/Updates
Table 105. Abbott Company Information
Table 106. Abbott Description and Business Overview
Table 107. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Abbott Peripheral Intervention Drug-Eluting Devices Product
Table 109. Abbott Recent Developments/Updates
Table 110. The Lubrizol Corporation Company Information
Table 111. The Lubrizol Corporation Description and Business Overview
Table 112. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product
Table 114. The Lubrizol Corporation Recent Developments/Updates
Table 115. Terumo Corporation Company Information
Table 116. Terumo Corporation Description and Business Overview
Table 117. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product
Table 119. Terumo Corporation Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Peripheral Intervention Drug-Eluting Devices Distributors List
Table 123. Peripheral Intervention Drug-Eluting Devices Customers List
Table 124. Peripheral Intervention Drug-Eluting Devices Market Trends
Table 125. Peripheral Intervention Drug-Eluting Devices Market Drivers
Table 126. Peripheral Intervention Drug-Eluting Devices Market Challenges
Table 127. Peripheral Intervention Drug-Eluting Devices Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Peripheral Intervention Drug-Eluting Devices
Figure 2. Global Peripheral Intervention Drug-Eluting Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peripheral Intervention Drug-Eluting Devices Market Share by Type: 2024 & 2031
Figure 4. Drug-Eluting Balloons Product Picture
Figure 5. Drug-Eluting Stents Product Picture
Figure 6. Global Peripheral Intervention Drug-Eluting Devices Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Peripheral Intervention Drug-Eluting Devices Market Share by Application: 2024 & 2031
Figure 8. Plain Old Balloon Angioplasty (POBA)
Figure 9. Percutaneous Transluminal Angioplasty (PTA)
Figure 10. Global Peripheral Intervention Drug-Eluting Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Peripheral Intervention Drug-Eluting Devices Market Size (2020-2031) & (US$ Million)
Figure 12. Global Peripheral Intervention Drug-Eluting Devices Sales (2020-2031) & (K Units)
Figure 13. Global Peripheral Intervention Drug-Eluting Devices Average Price (USD/Unit) & (2020-2031)
Figure 14. Peripheral Intervention Drug-Eluting Devices Report Years Considered
Figure 15. Peripheral Intervention Drug-Eluting Devices Sales Share by Manufacturers in 2024
Figure 16. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Peripheral Intervention Drug-Eluting Devices Players: Market Share by Revenue in Peripheral Intervention Drug-Eluting Devices in 2024
Figure 18. Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Peripheral Intervention Drug-Eluting Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2020-2031)
Figure 21. North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2020-2031)
Figure 25. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2020-2031)
Figure 26. Germany Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2020-2031)
Figure 33. China Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2020-2031)
Figure 44. Latin America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. U.A.E Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Peripheral Intervention Drug-Eluting Devices by Type (2020-2031)
Figure 54. Global Revenue Market Share of Peripheral Intervention Drug-Eluting Devices by Type (2020-2031)
Figure 55. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Peripheral Intervention Drug-Eluting Devices by Application (2020-2031)
Figure 57. Global Revenue Market Share of Peripheral Intervention Drug-Eluting Devices by Application (2020-2031)
Figure 58. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Application (2020-2031)
Figure 59. Peripheral Intervention Drug-Eluting Devices Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
